Literature DB >> 18482664

Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation.

Ann E Donald1, Julian P Halcox, Marietta Charakida, Clare Storry, Sharon M L Wallace, Tim J Cole, Peter Friberg, John E Deanfield.   

Abstract

OBJECTIVES: Our aim was to determine reproducibility of the flow-mediated dilation (FMD) response profile, and discriminatory ability of the components.
BACKGROUND: Brachial FMD is widely used to study conduit artery endothelial function. Automated B-mode image edge detection (B-ED) provides a full response profile. Reproducibility and biological relevance of these additional components have not been fully explored.
METHODS: Forty-two healthy adults underwent FMD using B-ED repeated at fixed time intervals up to 3 months. The FMD profile was assessed for diameter changes, area under the curve, and time course. Measures were compared in 25 adults with hypercholesterolemia, 25 subjects with diabetes, and 50 matched control subjects.
RESULTS: The maximum change in FMD was the most reproducible (coefficient of variation = 9.8%, 10.6%, 6.6%, and 9.2% at 4 to 6 h, 1 week, 1 month, and 3 months, respectively). Most of the variability occurred between subjects rather than within. All FMD measures except time course were significantly reduced in hypercholesterolemia and diabetes. Power curves were generated to indicate the appropriate number of subjects for parallel and crossover study designs.
CONCLUSIONS: Maximum FMD percentage change from baseline is the most reproducible of the response curve measures and best identifies those with risk factors. Flow-mediated dilation measured by B-ED is robust and practical to assess the effect of interventions on endothelial function in clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 18482664     DOI: 10.1016/j.jacc.2008.02.044

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  81 in total

Review 1.  Assessment of flow-mediated dilation in humans: a methodological and physiological guideline.

Authors:  Dick H J Thijssen; Mark A Black; Kyra E Pyke; Jaume Padilla; Greg Atkinson; Ryan A Harris; Beth Parker; Michael E Widlansky; Michael E Tschakovsky; Daniel J Green
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

2.  Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults.

Authors:  Gary L Pierce; Iratxe Eskurza; Ashley E Walker; Tara N Fay; Douglas R Seals
Journal:  Clin Sci (Lond)       Date:  2011-01       Impact factor: 6.124

3.  Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular function.

Authors:  Jonathan R Spiro; Janet E Digby; Gopal Ghimire; Mark Mason; Andrew G Mitchell; Charles Ilsley; Ann Donald; Miles C D Dalby; Rajesh K Kharbanda
Journal:  Eur Heart J       Date:  2010-10-29       Impact factor: 29.983

4.  Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial.

Authors:  Mary M McDermott; Christiaan Leeuwenburgh; Jack M Guralnik; Lu Tian; Robert Sufit; Lihui Zhao; Michael H Criqui; Melina R Kibbe; James H Stein; Donald Lloyd-Jones; Stephen D Anton; Tamar S Polonsky; Ying Gao; Rafael de Cabo; Luigi Ferrucci
Journal:  JAMA Cardiol       Date:  2017-08-01       Impact factor: 14.676

5.  Measuring FMD in the brachial artery: how important is QRS gating?

Authors:  Tinoy J Kizhakekuttu; David D Gutterman; Shane A Phillips; Jason W Jurva; Emily I L Arthur; Emon Das; Michael E Widlansky
Journal:  J Appl Physiol (1985)       Date:  2010-07-29

6.  Test-retest reliability of pulse amplitude tonometry measures of vascular endothelial function: implications for clinical trial design.

Authors:  Cindy E McCrea; Ann C Skulas-Ray; Mosuk Chow; Sheila G West
Journal:  Vasc Med       Date:  2012-02       Impact factor: 3.239

7.  Habitually exercising older men do not demonstrate age-associated vascular endothelial oxidative stress.

Authors:  Gary L Pierce; Anthony J Donato; Thomas J LaRocca; Iratxe Eskurza; Annemarie E Silver; Douglas R Seals
Journal:  Aging Cell       Date:  2011-10-17       Impact factor: 9.304

Review 8.  Is reversal of endothelial dysfunction still an attractive target in modern cardiology?

Authors:  Ify Mordi; Nikolaos Tzemos
Journal:  World J Cardiol       Date:  2014-08-26

9.  Assessment of vascular function in patients with chronic kidney disease.

Authors:  Kristen L Jablonski; Emily Decker; Loni Perrenoud; Jessica Kendrick; Michel Chonchol; Douglas R Seals; Diana Jalal
Journal:  J Vis Exp       Date:  2014-06-16       Impact factor: 1.355

10.  Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia.

Authors:  Catalin Mindrescu; Rakesh P Gupta; Eileen V Hermance; Mary C DeVoe; Vikas R Soma; John T Coppola; Cezar S Staniloae
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.